Stocks Down Under Videos

Get a 3-month FREE TRIAL to CONCIERGE now!

Concierge gives you timely BUY and SELL alerts on ASX-listed stocks

Test Concierge Now!

Cynata Therapeutics (ASX:CYP) is making steady progress: Interview with Dr. Kilian Kelly

October 13, 2025

CYP, Cynata Therapeutics

Cynata Therapeutics (ASX:CYP)

We spoke to Dr. Kilian Kelly, CEO of Cynata Therapeutics (ASX:CYP) about the three clinical studies currently ongoing that will read out data in the coming months, the earlier clinical data which has already pointed to efficacy, and the competitive advantage which its stem cells have over competing products.

 

Looking for the Best ASX Life Sciences stocks to invest in right now?

View All